1 January 2016 in Journal of Endourology
INTRODUCTION AND OBJECTIVES: Which ureteral stone can pass spontaneously? It is hard to answer this question exactly. The size and location of the stone are the most important predictors. However, there is still a considerable gray zone that needs to be clarified. We try to identify the role of stone volume in the prediction of spontaneous passage. MATERIALS AND METHODS: Seventy-eight patients with a solitary ureteral stone were retrospectively evaluated. Ureter stone volume measurements were taken in three planes and were calculated using the following formula: V = (X)x(Y)x(Z)x0.52. Stone volumes and the longest diameters were compared between patients who passed stones spontaneously and those who needed intervention. RESULTS: The stone volumes and longest diameters were significantly lower in patients who passed stones spontaneously than in patients who required intervention (41.2 ± 35.5 mm3 vs. 128.1 ± 91.1 mm3, p = 0.001; 5.7 ± 1.8 mm vs. 7.4 ± 1.7 mm, p = 0.001). The optimum cutoff values were 7.0 mm and 52.6 mm3 for the longest diameter and stone volume, respectively. For those stones of ≤ 7 mm, the volumes of the stones that could and could not pass did not differ significantly. However the volume of the stones > 7.0 mm that could pass was significantly higher than of those that could not. Spontaneous passage (SP) was 30.6% for stones > 7 mm; however, when we removed the stones > 52.6 mm3, SP increased to 75% for stones higher than 7 mm (p = 0.001). CONCLUSIONS: To classify ureteral stones using only one parameter such as stone diameter may lead to heterogeneity within the group. Stone volume may be used in addition to size to determine a more definite, homogeneous group in order to predict spontaneous passage more precisely.
1 January 2023 in Urology Research and Practice
Objective: The aim of this study is to evaluate current urologic practice regarding the management of priapism in Turkey and compare with international guidelines. Methods: Urologists and urology residents were invited to an online survey consisting of 30 multiple-choice questions on priapism-related clinical practices that were consid- ered most important and relevant to practices by using Google Forms. Results: Total number of responses was 340. Respondents reported that they recorded a detailed patient’s medical history and physical examination findings (n = 340, 100%) and laboratory testing, which includes corporal blood gas analysis (n=323, 95%). Participants announced that they performed Doppler ultrasound for 1/4 cases (n = 106, 31%), but 22% of the participants (n=75) replied that they performed in >75% of cases. Participants (n=311, 91%) responded that the first-line treatment of ischemic priapism is decompression of the corpus cavernosum. Moreover, most respondents (n = 320, 94%) stated that sympathomimetic injection drugs should be applied as the second step. About three-quarters of respondents (n = 247, 73%) indicated adrenaline as their drug of choice. Phosphodiesterase type 5 inhibitors seems to be the most pre- ferred drug for stuttering priapism (n=141, 41%). Participants (n=284, 84%) replied that corpora-glanular shunts should be preferred as the first. A large number of par- ticipants (n = 239, 70%) declared that magnetic resonance imaging can be performed in cases with delayed (>24 hours) priapism to diagnose corporal necrosis. Most of the participants (84%) responded that penile prosthesis should be preferred to shunts in cases with delayed (>48 hours) priapism. Conclusion: It would be appropriate to improve the training offered by professional associations and to give more training time to the management of priapism during residency. Cite this article as: Kalkanli A, Zeki Sönmez S, Guvel M, et al. Management of priapism: Results of a nationwide survey and comparison with international guidelines. Urol Res Pract. 2023;49(4):225-232.
6 September 2021 in Andrologia
Persistent Mullerian duct syndrome is a rare form disorder of sexual differentiation characterised by the persistence of Mullerian derivatives (fallopian tubes, uterus and the proximal vagina) in males with an XY karyotype and normal virilisation. We report a case of a 29-year-old man with right transverse testicular ectopia, mix germ cell cancer at ectopic right testis and left-sided obstructed inguinal hernia containing a uterus and fallopian tube. We performed orchiectomy and hysterectomy on the patient.
29 June 2025 in The New Journal of Urology
Squamous cell papilloma of the bladder is an exceedingly rare benign lesion. It is often identified incidentally during imaging studies performed for unrelated reasons and may mimic urothelial carcinoma of the bladder. The definitive diagnosis of this lesion, which can present with varying clinical symptoms, is established through pathological examination. Here, we report a case of squamous cell papilloma in a 56-year-old asymptomatic male patient. The patient underwent cystoscopy after a suspicious lesion was observed on full-abdominal CT imaging, raising concern for a bladder tumor. During cystoscopy, transurethral resection was performed on calcified exophytic lesions observed in the bladder, achieving complete resection of all lesions. Histopathological analysis revealed the lesion to be a squamous cell papilloma, and the patient was placed under follow-up. The etiology and clinical significance of these lesions, which are rarely reported in the literature, remain unclear. In this article, we summarize the case of squamous cell papilloma of the bladder while reviewing the relevant literature. We believe that this report contributes to the literature by emphasizing the importance of accurate pathological evaluation for urologists and preventing overly aggressive treatments for patients. Keywords: papilloma, squamous, bladder
28 October 2026 in The New Journal of Urology
Scrotal skin metastasis is extremely rare, predominantly originating from urogenital or gastrointestinal malignancies. Lung adenocarcinoma metastasis to the scrotum has been reported in only a limited number of cases in the literature. A 71-year-old male with a known diagnosis of lung adenocarcinoma presented with a progressively enlarging, painless 3 × 3 cm nodular mass in the right hemiscrotum. Histopathological and immunohistochemical examination confirmed metastatic pulmonary adenocarcinoma (TTF-1+, CK7+, P40−). The patient declined systemic therapy and experienced rapid disease progression, dying three months after the diagnosis of scrotal metastasis. This case highlights that metastatic disease should be considered in the differential diagnosis of scrotal lesions in patients with known malignancy, and underscores the value of immunohistochemistry in establishing the diagnosis.